68,419
Participants
Start Date
July 5, 2022
Primary Completion Date
November 1, 2024
Study Completion Date
November 1, 2024
Acute migraine treatment with any prescribed triptans
Sumatriptan, treximet (sumatriptan/naproxen combination), zolmitriptan, naratriptan, rizatriptan, almotriptan, eletriptan, and frovatriptan. No restriction on dose, frequency, duration, or delivery routes.
Standard of care management of acute migraine without triptans
Any standard of care management without triptans
Mayo Clinic Florida, Jacksonville
Mayo Clinic Minnesota, Rochester
Mayo Clinic Arizona, Phoenix
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
FED
Mayo Clinic
OTHER